FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Thursday reported second-quarter earnings of $1.61 billion.
On a per-share basis, the Foster City, California-based company said it had profit of $1.29. Earnings, adjusted for amortization costs and non-recurring costs, came to $2.01 per share.
The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.61 per share.
The HIV and hepatitis C drugmaker posted revenue of $6.95 billion in the period, which also beat Street forecasts. Ten analysts surveyed by Zacks expected $6.64 billion.
Gilead expects full-year earnings in the range of $3.60 to $3.90 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
